<DOC>
	<DOC>NCT00691717</DOC>
	<brief_summary>The purpose of this study was to evaluate the safety and intraocular-lowering efficacy of anecortave acetate depot when administered by anterior juxtascleral depot (AJD) for the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.</brief_summary>
	<brief_title>Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Anecortave</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Patients 18 years of age or older with openangle glaucoma (with or without pigment dispersion or pseudoexfoliation) or ocular hypertension. Other protocoldefined inclusion criteria may apply. Patients with any form of glaucoma other than openangle. Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Anecortave acetate</keyword>
	<keyword>Open-angle glaucoma</keyword>
	<keyword>IOP</keyword>
	<keyword>OHT</keyword>
</DOC>